Yang Y, Liu Z, Wang Q, Chang K, et al. Presence of CD133-positive circulating tumor cells predicts worse progression-free survival in patients with metastatic castration-sensitive prostate cancer. Int J Urol 2022 Jan 31. doi: 10.1111/iju.14801.
PMID: 35102615